Salivary Immune Responses in Malaria Vectors

Saliva of Anopheles mosquitoes contains a repertoire of bioactive proteins that modulate host coagulation, inflammation and immune defences at the bite site while simultaneously influencing Plasmodium development within the vector. Host antibodies against salivary components serve as serological biomarkers of exposure, revealing fine‐scale spatial and temporal heterogeneity in biting rates and transmission risk. Within the mosquito, salivary gland‐specific factors shape parasite colonisation of the midgut and sporozoite invasion of the glands, offering targets for transmission‐blocking interventions. Recent discoveries have elucidated mechanisms by which salivary proteins regulate haemostasis and immune signalling, identified vector‐derived antigens capable of inducing protective humoral responses, and revealed salivary factors whose genetic disruption impairs parasite development without compromising mosquito fitness. These insights underpin novel strategies to monitor transmission, evaluate control measures and design vaccines that target both vector saliva and parasite antigens, thereby interrupting the vector–host–pathogen cycle on a global scale.

Research from Nature Portfolio

Recent studies have characterised the role of anopheline salivary apyrase in regulating blood‐meal haemostasis and promoting Plasmodium transmission. Functional analyses revealed that mosquito apyrase interacts with host fibrinolytic pathways to degrade fibrin and inhibit platelet aggregation at the bite site, creating a microenvironment favourable to sporozoite survival and midgut infection. Immunisation against this apyrase in vertebrate hosts reduced parasite uptake by mosquitoes and impaired sporozoite development, highlighting a promising strategy to interrupt transmission at the vector–host interface.

Investigations into human IgG responses to the Anopheles gambiae salivary peptide gSG6‐P1 have validated its utility as a sensitive marker of bite exposure across transmission seasons. Field studies demonstrate that anti‐gSG6‐P1 antibody titres correlate strongly with entomological indicators such as human biting rates and sporozoite prevalence, enabling precise monitoring of vector control interventions in diverse ecological settings. This approach refines surveillance in low‐transmission areas and guides targeted deployment of control measures.

Salivary Immune Responses in Malaria Vectors publication trend

The graph below shows the total number of articles in salivary immune responses in malaria vectors across all publications each year (not limited to Nature Index journals).

Technical terms

Apyrase: Enzyme in mosquito saliva that hydrolyses adenosine diphosphate to inhibit platelet aggregation.

gSG6‐P1: Synthetic peptide derived from anopheline salivary protein gSG6, used as a serological marker of human exposure to mosquito bites.

Seroprevalence: Proportion of individuals in a population with detectable antibodies against a specific antigen.

Sporozoite: Infective stage of Plasmodium transmitted by mosquitoes to vertebrate hosts.

Humoral response: Immune reaction mediated by antibodies in body fluids against pathogens or antigens.

References

1. Mosquito salivary apyrase regulates blood meal hemostasis and facilitates malaria parasite transmission. Nature Communications (2024).
2. Utility of plasma anti-gSG6-P1 IgG levels in determining changes in Anopheles gambiae bite rates in a rural area of Cameroon. Scientific Reports (2024).
3. Geospatial joint modeling of vector and parasite serology to microstratify malaria transmission. Proceedings of the National Academy of Sciences of the United States of America (2024).
4. A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria. npj Vaccines (2023).
5. The salivary protein Saglin facilitates efficient midgut colonization of Anopheles mosquitoes by malaria parasites. PLOS Pathogens (2023).